Posts with tag Artificial Intelligence

Sort by Latest
EMA’s envisaged risk-based and human-centric approach to regulate AI
Bird & Bird’s international life sciences and healthcare team is at the forefront of the legal developments with regard to AI and the life sciences sector. This article is part of our new series, which will highlight different legal angles to consider when implementing AI in the life sciences and healthcare industry. Artificial Intelligence (“AI”) has emerged as a transformative force in the healthcare industry, and its significance for the pharmaceutical sector is particularly profound....
September 14, 2023
6 min read
AI as a Medical Device
To add to all the chatter about AI, let's talk about AI...
May 22, 2023
3 min read
What the replication crisis means for AI and drug ...
Back in May 2016, the scientific publication Nature surveyed...
May 4, 2023
2 min read
Artificial Intelligence Systems for Medical Diagno...
The Italian Ministry of Health has published a document on...
May 25, 2022
1 min read
Impact of Brexit on Artificial Intelligence in Healthcare
AI developments in the UK The UK is starting to uncover significant opportunities...
February 5, 2021
5 min read
Digital Technologies in Healthcare: The Liability Challenges
Digital technologies are increasingly transforming the way in which products are being made and services...
February 27, 2020
12 min read
From e-health to digital Health: Telemedicine, Electronic Healthcare File, Artificial Intelligence
In the last five decades we have been assisting on the digitalisation of society and consequently of...
June 24, 2019
23 min read